1 University of Texas M.D. Anderson Cancer Center, Houston, TX; American Society of Clinical Oncology, Alexandria, VA; Dana-Farber Cancer Institute, Boston MA.
Empirical approaches brought about use of the once-promising CSRA. However, oncologists now know that most cancers are highly complex, and that even the same tumor type can harbor differing genetic abnormalities.